Skip to main content
Premium Trial:

Request an Annual Quote

Hologic HPV Test Approved for Netherlands Cervical Screening Program

NEW YORK (GenomeWeb News) – Hologic today announced the Netherlands Society for Pathology has approved the use of the Hologic Cervista HPV HR test in the Dutch national cervical screening program.

The National Institute for Public Health and the Environment in the Netherlands suggests routine pap testing and HPV HR triage for the ASCUS/LSIL (or atypical squamous cells of undetermined significance/ low-grade squamous intraepithelial lesion) testing for women over the age of 30 in order to identify those most likely to develop cervical cancer, Hologic said.

The Cervista HPV HR test includes an internal control for verifying adequate cellularity for testing, reducing the number of false negative results, Rohan Hastie, Hologic vice president and general manager of diagnostics, said in a statement.

"More importantly, the test is designed to minimize false positive results due to a low-risk HPV strain being mistakenly recognized as a high-risk HPV strain, thereby potentially reducing unnecessary clinical management and patient anxiety. The test is built on redundancy and focused on the L1/E6E7 region so it protects against false negative outcomes in the event of L1 deletion," Hastie said.

The Bedford, Mass.-based firm is in the process of acquiring Gen-Probe for $3.7 billion and yesterday announced that the deal has been approved by German regulators.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.